Page last updated: 2024-09-05

sorafenib and azd4547

sorafenib has been researched along with azd4547 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(azd4547)
Trials
(azd4547)
Recent Studies (post-2010) (azd4547)
6,5207305,2511176116

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)azd4547 (IC50)
Fibroblast growth factor receptor 1Homo sapiens (human)0.006
Fibroblast growth factor receptor 2Homo sapiens (human)0.0052
Fibroblast growth factor receptor 4Homo sapiens (human)0.3382
Fibroblast growth factor receptor 3Homo sapiens (human)0.0068
Vascular endothelial growth factor receptor 2Homo sapiens (human)0.0383
Fibroblast growth factor receptor 4Mus musculus (house mouse)0.4335

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Feng, Y; He, G; He, S; Li, H; Liu, Y; Lu, G; Ren, L; Ren, X; Sun, H; Yin, Y; Zhang, D; Zhang, Z; Zhao, Y1

Other Studies

1 other study(ies) available for sorafenib and azd4547

ArticleYear
AZD4547 and the Alleviation of Hepatoma Cell Sorafenib Resistance via the Promotion of Autophagy.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:18

    Topics: Autophagy; Beclin-1; Benzamides; Carcinoma, Hepatocellular; Cell Line; Cell Line, Tumor; Cell Proliferation; Humans; Liver Neoplasms; Piperazines; Pyrazoles; Receptors, Fibroblast Growth Factor; Saline Solution; Sorafenib; Toll-Like Receptor 4

2022